Cargando…

Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales

INTRODUCTION: SARS-CoV-2 (COVID-19) is a novel coronavirus that emerged in Wuhan, China in late 2019 and since become a global pandemic. As such, its clinical behaviour is a subject of much interest. Initial reports suggested a significant proportion of patients have abnormal liver blood tests. Gwen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeoman, Andrew, Maggs, Daniel Raun, Gardezi, Syed A A, Haboubi, Hasan Nadim, Yahya, Muhammad Imran, Yousuf, Fidan, Czajkowski, Marek Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873537/
https://www.ncbi.nlm.nih.gov/pubmed/33617606
http://dx.doi.org/10.1136/flgastro-2020-101532
_version_ 1783649406975737856
author Yeoman, Andrew
Maggs, Daniel Raun
Gardezi, Syed A A
Haboubi, Hasan Nadim
Yahya, Muhammad Imran
Yousuf, Fidan
Czajkowski, Marek Alexander
author_facet Yeoman, Andrew
Maggs, Daniel Raun
Gardezi, Syed A A
Haboubi, Hasan Nadim
Yahya, Muhammad Imran
Yousuf, Fidan
Czajkowski, Marek Alexander
author_sort Yeoman, Andrew
collection PubMed
description INTRODUCTION: SARS-CoV-2 (COVID-19) is a novel coronavirus that emerged in Wuhan, China in late 2019 and since become a global pandemic. As such, its clinical behaviour is a subject of much interest. Initial reports suggested a significant proportion of patients have abnormal liver blood tests. Gwent has experienced one of the highest incidences of COVID-19 infection in the UK, which itself has among the highest COVID-19 impacts worldwide. METHOD: We set out to report the incidence, clinical pattern and severity of liver blood test abnormalities in hospitalised patients with confirmed COVID-19 in our institution over a 3-week period. Data on clinical outcomes such as admission to intensive therapy unit (ITU), hospital discharge and mortality were recorded. RESULTS: 318 hospitalised COVID-19 positive had liver blood tests available for analysis. Ninety-seven patients (31%) had one or more abnormal liver blood tests and were abnormal admission in 64%. Liver tests were predominantly cholestatic (72%) in contrast to other studies to date. Male gender and abnormal liver blood tests were associated with ITU admission. CONCLUSIONS: Almost one-third of admissions with COVID-19 have abnormal LBTs which are typically mild and are associated with male gender. Importantly, we have identified that cholestatic patterns dominate but were not clearly associated with ITU admission or death.
format Online
Article
Text
id pubmed-7873537
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-78735372021-02-18 Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales Yeoman, Andrew Maggs, Daniel Raun Gardezi, Syed A A Haboubi, Hasan Nadim Yahya, Muhammad Imran Yousuf, Fidan Czajkowski, Marek Alexander Frontline Gastroenterol Liver INTRODUCTION: SARS-CoV-2 (COVID-19) is a novel coronavirus that emerged in Wuhan, China in late 2019 and since become a global pandemic. As such, its clinical behaviour is a subject of much interest. Initial reports suggested a significant proportion of patients have abnormal liver blood tests. Gwent has experienced one of the highest incidences of COVID-19 infection in the UK, which itself has among the highest COVID-19 impacts worldwide. METHOD: We set out to report the incidence, clinical pattern and severity of liver blood test abnormalities in hospitalised patients with confirmed COVID-19 in our institution over a 3-week period. Data on clinical outcomes such as admission to intensive therapy unit (ITU), hospital discharge and mortality were recorded. RESULTS: 318 hospitalised COVID-19 positive had liver blood tests available for analysis. Ninety-seven patients (31%) had one or more abnormal liver blood tests and were abnormal admission in 64%. Liver tests were predominantly cholestatic (72%) in contrast to other studies to date. Male gender and abnormal liver blood tests were associated with ITU admission. CONCLUSIONS: Almost one-third of admissions with COVID-19 have abnormal LBTs which are typically mild and are associated with male gender. Importantly, we have identified that cholestatic patterns dominate but were not clearly associated with ITU admission or death. BMJ Publishing Group 2020-08-21 /pmc/articles/PMC7873537/ /pubmed/33617606 http://dx.doi.org/10.1136/flgastro-2020-101532 Text en © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage
spellingShingle Liver
Yeoman, Andrew
Maggs, Daniel Raun
Gardezi, Syed A A
Haboubi, Hasan Nadim
Yahya, Muhammad Imran
Yousuf, Fidan
Czajkowski, Marek Alexander
Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales
title Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales
title_full Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales
title_fullStr Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales
title_full_unstemmed Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales
title_short Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales
title_sort incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with sars-cov2 (covid-19) in south wales
topic Liver
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873537/
https://www.ncbi.nlm.nih.gov/pubmed/33617606
http://dx.doi.org/10.1136/flgastro-2020-101532
work_keys_str_mv AT yeomanandrew incidencepatternandseverityofabnormalliverbloodtestsamonghospitalisedpatientswithsarscov2covid19insouthwales
AT maggsdanielraun incidencepatternandseverityofabnormalliverbloodtestsamonghospitalisedpatientswithsarscov2covid19insouthwales
AT gardezisyedaa incidencepatternandseverityofabnormalliverbloodtestsamonghospitalisedpatientswithsarscov2covid19insouthwales
AT haboubihasannadim incidencepatternandseverityofabnormalliverbloodtestsamonghospitalisedpatientswithsarscov2covid19insouthwales
AT yahyamuhammadimran incidencepatternandseverityofabnormalliverbloodtestsamonghospitalisedpatientswithsarscov2covid19insouthwales
AT yousuffidan incidencepatternandseverityofabnormalliverbloodtestsamonghospitalisedpatientswithsarscov2covid19insouthwales
AT czajkowskimarekalexander incidencepatternandseverityofabnormalliverbloodtestsamonghospitalisedpatientswithsarscov2covid19insouthwales